Related Experiment Video
Updated: Apr 30, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Review Article: CD151 and TGF-β in Colon Cancer Metastasis: Flavonoids and Their Targeted Delivery Systems.
Rama Rao Malla1, Durga Bhavani Kundrapu2, B Priyamavada1
1Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GITAM School of Science, GITAM (Deemed to Be University), Visakhapatnam-530045, Andhra Pradesh, India.
Natural flavonoids like quercetin, taxifolin, and rutin show promise in combating colon cancer (CC) metastasis. These compounds may interfere with signaling pathways, offering a potential strategy to reduce CC mortality.
Area of Science:
- Oncology
- Natural Product Chemistry
- Molecular Biology
Background:
- Colon cancer (CC) is a leading cause of cancer mortality worldwide.
- Metastasis is the primary driver of increased mortality in colon cancer patients.
- Natural compounds are being explored for their potential to target multiple cancer mechanisms.
Purpose of the Study:
- To review the potential of specific natural flavonoids in mitigating colon cancer metastasis.
- To explore the role of quercetin, taxifolin, and rutin in targeting colon cancer signaling pathways.
Main Methods:
- Literature review focusing on natural flavonoids and colon cancer.
- Analysis of signaling pathways implicated in colon cancer metastasis.
- Examination of the molecular mechanisms of quercetin, taxifolin, and rutin.
Main Results:
- Flavonoids like quercetin, taxifolin, and rutin exhibit potential anti-metastatic properties in colon cancer.
- These compounds may modulate key signaling pathways involved in cancer progression.
- Evidence suggests interference with the expression or activity of specific signaling targets.
Conclusions:
- Natural flavonoids represent a promising avenue for colon cancer therapeutic strategies.
- Quercetin, taxifolin, and rutin may offer a multi-targeted approach to inhibit colon cancer metastasis.
- Further research into these compounds could lead to novel treatments for colon cancer.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
TGF - β Signaling Pathway